Last edition
News about Industrial talks
Zeon Lifesciences plans to export its nutraceutical products to ten more countries
The company plans to export herbal and ayurvedic products manufactured in its state-of-the-art manufacturing unit in Himachal Pradesh, India, to ten more international markets. These global markets include the United States, Kenya, the United Arab Emirates, Russia, Uzbekistan, Saudi Arabia, Zambia, South Africa, Iran, and the United Kingdom
Industrial talks | 23/02/2022 | By Darshana | 558
This is the beginning of a long term partnership which shall begin with Skye Air conducting BVLOS drone delivery trials in a select corridor and subsequently followed on by commercial roll-outs in several urban and remote locations in India
Industrial talks | 09/02/2022 | By Darshana | 319
IAFM organizes conference to promote and spread awareness on functional medicines in India
The Indian Association of Functional Medicine, an independent body launched its first conference with the objective of promoting the usage of Functional medicines in our day to day lives and reducing the dependency on other medicines that act on the symptom and subside the overall problem in a person?s body than acting on the actual underlying problem
Industrial talks | 22/12/2021 | By Darshana | 579
Pharmexcil to organize seminar on "Reinvigorating India's Pharma Exports" on December 23 in Chennai
In an effort to revitalize pharmaceutical exporters of Tamil Nadu after the prolonged Covid shock, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) is organizing a one-day seminar on the subject ?Reinvigorating India?s Pharma Exports?, focusing latest pharmaceutical export policies and regulations
Industrial talks | 22/12/2021 | By Darshana | 258
Piramal Pharma to invest minority stake in Yapan Bio
Piramal Pharma Limited (PPL) announced an investment of Rs. 101.77 crore in Yapan Bio Pvt Ltd of Hyderabad, India, augmenting the capabilities of its contract development and manufacturing organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment
Industrial talks | 21/12/2021 | By Darshana | 528
Cipla to acquire 33 per cent stake in Clean Max Auriga Power
In line with the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a captive user under electricity laws, the company has entered into agreements to acquire up to 33 per cent partnership interest in Clean Max Auriga Power LLP, the drug maker said in a regulatory filing
Industrial talks | 17/12/2021 | By Darshana | 231
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Syngene International yesterday announced the extension of its long-standing multi-discipline research collaboration with Amgen Inc. The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents
Industrial talks | 17/12/2021 | By Darshana | 351
NPPA fixes retail price of 20 new drugs
The National Pharmaceutical Pricing Authority (NPPA) has announced retail price fixation of 20 new drugs based on the decision of its Authority meeting held on November 15, 2021. Out of the total new drugs for which the prices were fixed, 17 were combinations containing diabetes drug Dapagliflozin, which was patented by drug major AstraZeneca
Industrial talks | 07/12/2021 | By Darshana | 306
Informa Pharma Intelligence announced the 2021 hybrid edition of CPhI and P-Mec conducted by CPhI Conference. The online conference and networking is being held between 15th and 30th Nov 2021, while the in-person event was held between 24th and 26th November, 2021 at India Expo Centre? Greater Noida, according to a statement by Informa
Industrial talks | 27/11/2021 | By Darshana | 188
GlobalData: Indian pharma should grab opportunities to supply oral Covid-19 drugs to global market
The Indian pharma manufacturers may see more demand for oral Covid-19 drugs from various parts of the world, as a larger opportunity in the global supply pool is opening up, says GlobalData, a leading data and analytics company.
Industrial talks | 21/11/2021 | By Darshana | 239
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy